华熙生物：控股股东增持0.94%

Core Viewpoint - The controlling shareholder of Huaxi Biological, Huaxi Xinyu Investment Co., Ltd., has completed a share buyback plan, increasing its stake in the company significantly [1] Summary by Relevant Sections - Share Buyback Details - From August 27, 2025, to September 30, 2025, Huaxi Xinyu Investment Co., Ltd. acquired a total of 4.5187 million shares through centralized bidding on the Shanghai Stock Exchange, representing 0.94% of the company's total share capital [1] - The total amount spent on the buyback was 257 million yuan [1] - Shareholding Changes - Prior to the buyback, Huaxi Xinyu held 283 million shares, accounting for 58.86% of the total shares [1] - After the buyback, the total shares held increased to 290 million, raising the ownership percentage to 60.11% [1] - Completion of Buyback Plan - The share buyback plan has been fully implemented as of the announcement date [1]